Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
---|
02/01/2007 | US20070026017 Brachyspira pilosicoli 72kda outer-membrane protein and diagnostic and therapeutic uses thereof |
02/01/2007 | US20070026015 Method |
02/01/2007 | US20070026002 treatment of mammals susceptible to or diagnosed with cancer, or with relapse tumor growth or relapse cancer cell growth |
02/01/2007 | US20070025998 Methods for enhancing the efficacy of cancer therapy |
02/01/2007 | US20070025996 Oculospanin as a tumor specific antigen and methods and compositions utilizing same |
02/01/2007 | US20070025981 Microorganisms for therapy |
02/01/2007 | US20070025975 Oligodendrocyte determination genes and uses thereof |
02/01/2007 | US20070025974 Amylases producing an altered immunogenic response and methods of making and using the same |
02/01/2007 | US20070025971 Substances causing differentiation |
02/01/2007 | US20070025970 Vector system |
02/01/2007 | US20070025969 RNAi expression constructs |
02/01/2007 | US20070025968 Methods for selecting and producing T cell peptide epitopes and vaccines incorporating said selected epitopes |
02/01/2007 | US20070025967 Zap protein and related compositions and methods |
02/01/2007 | US20070025913 Immunoglobulin which specifically binds endothelial cell-specific polypeptides; for use as evaluative tool in immunodiagnostic and drug efficacy studies |
02/01/2007 | DE102005035568A1 Frizzled 9 als Biomarker für Substrukturen des humanen Gehirns Frizzled 9 as a biomarker for substructures of the human brain |
02/01/2007 | DE10141443B4 Verwendung von molekularbiologisch hergestellten, nicht-viralen Wirkstoffen zur Behandlung der Akne Using molecular biological manufactured, non-viral agents for the treatment of acne |
02/01/2007 | CA2616877A1 Systems and methods for manufacturing liposomes |
02/01/2007 | CA2616209A1 Tandem cardiac pacemaker system |
02/01/2007 | CA2607668A1 Rnai modulation of the rho-a gene and uses thereof |
01/31/2007 | EP1748075A1 Recombinant chemokine-antigen vaccine |
01/31/2007 | EP1748069A1 Follistatin mutant polypeptide |
01/31/2007 | EP1748046A2 Inhibitors of histone deacetylase |
01/31/2007 | EP1747462A2 Methods, agents, and compound screening assays for inducing differentiation of undifferentiated mammalian cells into osteoblasts |
01/31/2007 | EP1747277A1 Method for gene delivery to neuronal cells |
01/31/2007 | EP1747226A1 Pharmaceuticals for enhanced deliver to disease targets |
01/31/2007 | EP1747024A2 Dna virus microrna and methods for inhibiting same |
01/31/2007 | EP1747023A2 Methods and compositions for reducing viral genome amounts in a target cell |
01/31/2007 | EP1747022A2 INHIBITION OF HAIRLESS PROTEIN mRNA |
01/31/2007 | EP1392838B1 Pseudotyping of hiv vectors with mokola virus envelopes |
01/31/2007 | EP0804574B1 Human kappa opioid receptor, nucleic acids and uses thereof |
01/31/2007 | CN1906302A Genetically modified plants comprising SARS-CoV viral nucleotide sequences and methods of use thereof for immunization against SARS |
01/31/2007 | CN1906301A HIV-1 Indian subtype C vaccine constructs for use in humans |
01/31/2007 | CN1906297A IL-23 and its receptor, related reagents and methods |
01/31/2007 | CN1906205A Reduction of dermal scarring |
01/31/2007 | CN1906162A Hydroxy piperidine derivatives to treat gaucher disease |
01/31/2007 | CN1904900A Human autogenous siRNA sequence, its application and screening method |
01/31/2007 | CN1904056A Recombinant adeno-associated virus comprising VEGFR Truncated Soluble cDNA and gene therapeutic agent comprising the same |
01/31/2007 | CN1904055A Targeted liposome gene delivery |
01/31/2007 | CN1904054A Poultry infectivity bronchitis DNA vaccine pIBM and application |
01/31/2007 | CN1904046A Single chain deoxynucleotide of anti human immune deficiency virus |
01/31/2007 | CN1903877A Antitumour vascular endothelial growth factor receptor VEGF-R antigen and its coding gene and application |
01/31/2007 | CN1903876A Polypeptide, nucleic acid molecule coding it and use |
01/31/2007 | CN1903870A Single chain DNA having therapeutic action against virus infection disease |
01/31/2007 | CN1903373A Application of expression TRAIL protein colon bacillus for preparing medicine to treat tumor |
01/31/2007 | CN1903372A Three gene combination DNA vaccine for avian infectious bronchitis, and application thereof |
01/31/2007 | CN1903371A DNA vaccine pIBN for avian infectious bronchitis, and application thereof |
01/31/2007 | CN1903370A DNA vaccine pIBS1 for avian infectious bronchitis and application thereof |
01/31/2007 | CN1903363A Mosaic type virus-like particle DNA vaccine |
01/31/2007 | CN1297320C Hair follicle-reconstitution system and animal carrying the same |
01/30/2007 | US7169917 Purification of plasmid DNA by hydrophobic interaction chromatography |
01/30/2007 | US7169904 Immunocytokine sequences and uses thereof |
01/30/2007 | US7169898 Soluble CD83 proteins and use thereof for the treatment or prevention of a disease or medical condition caused by dysfunction or undesired function of a cellular immune response involving T cells |
01/30/2007 | US7169758 Use of hepcidin as a regulator of iron homeostasis |
01/30/2007 | US7169605 Methods of controlling proliferation and differentiation of stem and progenitor cells |
01/30/2007 | US7169603 Nucleic acid; a nucleotide sequence encoding a fusion polypeptide; fusion polypeptides containing alpha -MSH can be used to elicit a variety of biological responses, in vitro and in vivo |
01/30/2007 | US7169565 Isolated antibody that specifically binds to a polypeptide encoded by polynucleotides composed of any polyribonucleotide or polydeoxribonucleotide, which may be unmodified RNA or DNA or modified RNA or DNA |
01/30/2007 | US7169559 Using low density lipoprotein related proteins (LRP) to diagnose, treat and prevent paget's, osteoporosis, cirrhosis and rickets |
01/30/2007 | US7169384 Gene for which is located on the short arm of human chromosome 1; gene is directly implicated in colon, kidney and breast cancers |
01/30/2007 | CA2284859C Nucleic acid molecule for a human skeletal muscle-specific receptor |
01/30/2007 | CA2167693C Melanoma-inhibiting protein |
01/30/2007 | CA2166973C Immortalized human fetal osteoblastic cells |
01/30/2007 | CA2107537C Inhibition of tumor cell growth by administration of b7-transfected cells |
01/25/2007 | WO2007010999A1 Animal in which lipid metabolism and sugar metabolism are modified by krap gene mutation, modification method and modifying agent |
01/25/2007 | WO2007010853A1 Method for control of electroporation apparatus |
01/25/2007 | WO2007010840A1 MULTIPLE shRNA EXPRESSION VECTOR |
01/25/2007 | WO2007010628A1 Prophylactic/therapeutic agent for cancer |
01/25/2007 | WO2006105279A9 Defective sindbis viral vectors |
01/25/2007 | WO2006085226A3 Blockade of airway hyperresponsiveness and inflammation in a murine model of asthma by insulin-like growth factor binding protein-3 (igfbp-3) |
01/25/2007 | WO2006071200A3 Chinese hamster apoptosis-related genes |
01/25/2007 | WO2006060680A3 Mda-7 protein variants having antiproliferative activity |
01/25/2007 | WO2005118824A8 Methods and compositions for the inhibition of gene expression |
01/25/2007 | WO2004063342A3 Cellular delivery and activation polypeptide-nucleic acid complexes |
01/25/2007 | US20070021589 Obesity-related genes |
01/25/2007 | US20070021375 Genetic modification of targeted regions of the cardiac conduction system |
01/25/2007 | US20070021374 polypeptides derived from Streptococcus pneumoniae including surface or secreted proteins or parts thereof, that are useful as molecular targets for diagnostics, prophylaxis and treatment of bacterial infection; vaccines |
01/25/2007 | US20070021373 Administering polypeptide which elicits an immune response |
01/25/2007 | US20070021372 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
01/25/2007 | US20070021371 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
01/25/2007 | US20070021370 Administering polypeptide which elicits immune response; antibodies useful as probes for detection; vaccines |
01/25/2007 | US20070021369 Nucleic acid and amino acid sequences relating to streptococcus pneumoniae for diagnostics and therapeutics |
01/25/2007 | US20070021368 Administering polypeptide to elicit immune response; pneumonia, otitis media; biodrugs |
01/25/2007 | US20070021367 Modulation of SOCS-3 expression |
01/25/2007 | US20070021366 Structural-based inhibitors of the glutathione binding site in aldose reductase, methods of screening therefor and methods of use |
01/25/2007 | US20070021365 Inhibition of Lysyl oxidase for treating tumor growth and diagnostics relating thereto |
01/25/2007 | US20070021364 Methods for genetic immunization |
01/25/2007 | US20070021363 Genomic replacement therapy |
01/25/2007 | US20070021362 Antisense antibacterial method and compound |
01/25/2007 | US20070021361 Methods and materials for modulating trpm2 |
01/25/2007 | US20070021360 Compositions, formulations and kit with anti-sense oligonucleotide and anti-inflammatory steroid and/or obiquinone for treatment of respiratory and lung disesase |
01/25/2007 | US20070021337 Novel agent for inducing apoptosis comprising Msx1 or a gene encoding the same as an active ingredient |
01/25/2007 | US20070021327 Methods and compositions for treatment of tumors using nucleic acid ligands to platelet-derived growth factor |
01/25/2007 | US20070021323 Use of a nitroxide or a prodrug thereof in the prophylactic and therapeutic treatment of cancer |
01/25/2007 | US20070020761 Solid surface for biomolecule delivery and high-throughput assay |
01/25/2007 | US20070020730 Method for overexpression of zwitterionic polysaccharides |
01/25/2007 | US20070020679 Modulation of HIF1alpha and HIF2alpha expression |
01/25/2007 | US20070020673 Model of autoimmune disease and methods for identifying agents against autoimmune disease |
01/25/2007 | US20070020666 Differentially expressed genes in large granular lymphocyte leukemia |
01/25/2007 | US20070020635 Nucleotides for prevention and treatment of bacterial and fungal pathologies |
01/25/2007 | US20070020632 Method for selective inhibition of human n-myc gene in n-myc expressing tumors through antisense and antigen peptido-nucleic acids (pna) |
01/25/2007 | US20070020630 Methods of identifying compounds that target trna splicing endonuclease and uses of said compounds as anti-proliferative agents |